The 100 mg and 300 mg vials of zolbetuximab contain an overfill of 5 mg/vial and 15 mg/vial, respectively, to ensure the intended deliverable dose
Zolbetuximab must be reconstituted with 5.0 mL (100 mg/vial) or 15.0 mL (300 mg/vial) of sterile water for injection, which gives a solution concentration of 20 mg/mL in a vial.1 The extractable amount of zolbetuximab after reconstitution will be either 100 mg or 300 mg.
Table 1. Amount of active ingredient per vial1
Component | Amount per 100 mg vial | Amount per 300 mg viala |
|---|---|---|
Zolbetuximab | 105 mg | 315 mg |
a Not all vial sizes of zolbetuximab may be approved in your country. Please refer to the local prescribing label for further information.
Data on File.
The medical information on this website is for educational purposes only and is intended to provide scientific information about Astellas products. This information is not intended as medical advice or clinical recommendations. This website is for use only by United States residents and licensed healthcare professionals (HCPs) practicing in the United States. Product labeling may vary between countries.
Please choose an option that best describes you:
For visitors outside the United States: click here